Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Journal of Clinical Microbiology
|
September 1, 1993
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates
S H Siddiqi, L B Heifets, M H Cynamon, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients
S L Koletar, A J Berry, M H Cynamon, et al.
Plos One
|
June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis
Karen G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Journal of Medicinal Chemistry
|
September 29, 1995
Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity
M H Cynamon, R Gimi, F Gyenes, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 26, 2001
Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis
K M Edwards, M H Cynamon, R K Voladri, et al.
Vaccines
|
September 8, 2015
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
Carolyn M Shoen, Michelle S DeStefano, Cynthia C Hager, et al.
Biochemical Pharmacology
|
December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus
Mihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology
|
May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones
Yashang Lee, Sara Mootien, Carolyn Shoen, et al.
Journal of Medical Microbiology
|
November 19, 1997
Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis
T C Victor, R Warren, J L Butt, et al.
European Journal of Medicinal Chemistry
|
June 16, 2009
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid
Michael J Hearn, Michael H Cynamon, Michaeline F Chen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Journal of Clinical Microbiology
|
September 1, 1993
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates
S H Siddiqi, L B Heifets, M H Cynamon, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients
S L Koletar, A J Berry, M H Cynamon, et al.
Plos One
|
June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis
Karen G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Journal of Medicinal Chemistry
|
September 29, 1995
Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity
M H Cynamon, R Gimi, F Gyenes, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 26, 2001
Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis
K M Edwards, M H Cynamon, R K Voladri, et al.
Vaccines
|
September 8, 2015
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
Carolyn M Shoen, Michelle S DeStefano, Cynthia C Hager, et al.
Biochemical Pharmacology
|
December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus
Mihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology
|
May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones
Yashang Lee, Sara Mootien, Carolyn Shoen, et al.
Journal of Medical Microbiology
|
November 19, 1997
Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis
T C Victor, R Warren, J L Butt, et al.
European Journal of Medicinal Chemistry
|
June 16, 2009
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid
Michael J Hearn, Michael H Cynamon, Michaeline F Chen, et al.
Page
of 10